Gilead Sciences, Inc.
Status: Publicly traded
Direct answer
Gilead Sciences, Inc. is publicly traded on NASDAQ under the ticker GILD.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key...
Can you invest in Gilead Sciences, Inc.?
Yes. Gilead Sciences, Inc. is publicly traded on NASDAQ under the ticker GILD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Gilead Sciences, Inc.
Detailed equity research is provided by MarketSnap.